Publication details
Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment
| Authors | |
|---|---|
| Year of publication | 2013 |
| Type | Article in Periodical |
| Magazine / Source | LEUKEMIA & LYMPHOMA |
| MU Faculty or unit | |
| Citation | |
| Doi | http://dx.doi.org/10.3109/10428194.2012.738816 |
| Field | Oncology and hematology |
| Keywords | SCLEROMYXEDEMA; DEXAMETHASONE; ADULTORUM; BUSCHKE; THALIDOMIDE; DISORDERS; PATIENT; DISEASE |
| Description | Scleredema is a rare scleroderma-like fi bromucinosis characterized by progressive thickening of the skin caused by excessive collagen and mucin depositions in the dermis. Various treatment regimens have been proposed, however with inconsistent outcomes. Herein we are the fi rst to report a complete dermatological and hematological remission in a patient with multiple myeloma associated scleredema after bortezomib-based chemotherapy. |
| Related projects: |
|